Meet Professor Lance Kriegsfield

Professor Kriegsfeld’s work has been funded by The National Institutes of Health, The National Science Foundation, industry, and philanthropy. His principal line of research focuses on the role of circadian timing in physical and mental health, applying behavioral, histological, cell and tissue culture, pharmacological, molecular biological, and computational approaches to examine questions of interest from neural circuits and specific genes to neurochemical systems and behavior. 

His group has used these approaches to investigate the role of circadian rhythms in aging and cognitive decline, female reproductive health, mental health, neurobehavioral development, and sleep. Professor Kriegsfeld’s work applies what he has learned from preclinical models and basic science to human populations to develop strategies to maximize mental and physiological health. 

Professor Kriegsfeld is committed to intra-and extramural service, serving as Vice Chair in the Department of Psychology at Berkeley and routinely serving on National Institutes of Health study sections and journal editorial boards. Professor Kriegsfeld has won several awards for research and service, including the Frank A. Beach Award in Behavioral Neuroendocrinology, the Berkeley Faculty Award for Excellence in Postdoctoral Mentoring, and the Department of Psychology Outstanding Service Award.

How Lance Supports OptoCeutics
Lance Kriegsfeld supports Optoceutics with his extensive background in animal research and preclinical study design. Leveraging his expertise in conducting rigorous preclinical trials, Dr. Kriegsfeld facilitates the use of Optoceutics’ devices in animal models to investigate mechanisms of action and potential therapeutic effects.

His role encompasses overseeing the design, implementation, and analysis of preclinical studies, ensuring that findings provide robust translational insights relevant to human clinical applications. This foundational research strengthens the company’s understanding of device efficacy and safety, laying the groundwork for successful clinical advancements.